These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3228497)
1. [Natural killer (NK) activity in patients with HIV infection]. Ortona L; Tamburrini E; Tumbarello M; Ventura G; Cauda R Boll Ist Sieroter Milan; 1988; 67(2):135-41. PubMed ID: 3228497 [TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients. Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL Thymus; 1997; 24(3):147-56. PubMed ID: 9151380 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. Bonavida B; Katz J; Gottlieb M J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody. Sirianni MC; Mezzaroma I; Aiuti F; Moretta A Eur J Immunol; 1994 Aug; 24(8):1874-8. PubMed ID: 8056046 [TBL] [Abstract][Full Text] [Related]
8. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection. Ljunggren K; Karlson A; Fenyö EM; Jondal M Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286 [TBL] [Abstract][Full Text] [Related]
9. Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection. Morsica G; Tasca S; Biswas P; Galli A; Malnati M; Paties C; Marinelli M; Bagaglio S; Lazzarin A; Fortis C Scand J Immunol; 2005 Sep; 62(3):318-24. PubMed ID: 16179020 [TBL] [Abstract][Full Text] [Related]
10. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Lucia B; Jennings C; Cauda R; Ortona L; Landay AL Cytometry; 1995 Mar; 22(1):10-5. PubMed ID: 7587727 [TBL] [Abstract][Full Text] [Related]
11. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I. Nair MP; Schwartz SA Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529 [TBL] [Abstract][Full Text] [Related]
13. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136 [TBL] [Abstract][Full Text] [Related]
14. Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line. Sirianni MC; De Sanctis G; Macchi B; Soddu S; Ensoli F; Aiuti F; Fontana L Diagn Clin Immunol; 1988; 5(6):297-303. PubMed ID: 3219779 [TBL] [Abstract][Full Text] [Related]
15. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. Ahmad R; Sindhu ST; Tran P; Toma E; Morisset R; Menezes J; Ahmad A J Med Virol; 2001 Nov; 65(3):431-40. PubMed ID: 11596074 [TBL] [Abstract][Full Text] [Related]
16. Loss of T-cell cytotoxic responses in the course of HIV-1 infection. Zerhouni B; Sanhadji K; Touraine JL Thymus; 1997; 24(4):203-19. PubMed ID: 9493284 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic changes in monocytes and alveolar macrophages in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). Roy G; Rojo N; Leyva-Cobián F J Clin Lab Immunol; 1987 Jul; 23(3):135-41. PubMed ID: 3118038 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects. Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome. Reddy MM; Chinoy P; Grieco MH J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880 [TBL] [Abstract][Full Text] [Related]
20. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection]. Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]